MENU
RLMD
AS OF
Sep 15 closing price
Price
$1.67
Change
+$0.08 (+5.03%)
Capitalization
55.43M
51 days until earnings call
RLMD
Stock ticker: NASDAQ
AS OF
Sep 15 closing price
Price
$1.67
Change
+$0.08 (+5.03%)
Capitalization
55.43M
RLMD Relmada Therapeutics Chart, History Price & Graph
a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases
Show more...
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RLMD showed earnings on August 07, 2025. You can read more about the earnings report here.
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
RLMD and Stocks
Correlation & Price change
A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then SYRE could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To RLMD | 1D Price Change % | ||
|---|---|---|---|---|
| RLMD | 100% | +5.03% | ||
| SYRE - RLMD | 36% Loosely correlated | -5.18% | ||
| ENTO - RLMD | 36% Loosely correlated | +13.97% | ||
| PRTC - RLMD | 31% Poorly correlated | -4.29% | ||
| AVXL - RLMD | 31% Poorly correlated | -3.04% | ||
| ZVRA - RLMD | 29% Poorly correlated | -6.71% | ||
More | ||||